Purity >98%. Docosatetraenoyl ethanolamide (DEA) is an endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA. DEA acts on CB1 receptors with potency and efficacy similar to that of AEA. However, its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated.
Size
n/a
Concentration
n/a
Applications
n/a
Other Names
N-(2-hydroxyethyl)-7Z,10Z,13Z,16Z-docosatetraenamide, DEA